Population
Children and adults with congenital heart disease
Design
Review
Authors
Loading...
Does not alter current congenital interventions; leaves open prospective validation of bespoke, bioresorbable, and tissue-engineered devices.
This review highlights the exponential growth in minimally invasive interventions for congenital heart disease and emphasizes the need for dedicated equipment, bioresorbable materials, and collaborative approaches to address the unique challenges of somatic growth.
Damien Kenny (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: